GeneQuine Biotherapeutics to Present at 2015 KC Animal Health Investment Forum (September 1, 2015, Kansas City)

GeneQuine Biotherapeutics, developing gene therapy for joint diseases, will present at 2015 KC Animal Health Investment Forum. The KC Animal Health Investment Forum provides a unique opportunity for companies in the animal health sector to present their vision and business plan to potential investors and development Partners.

GeneQuine’s CEO Dr. Kilian Guse will showcase the company’s technology and veterinary product candidates as well as the recent results from a proof-of-concept study in horses demonstrating symptomatic and disease-modifying treatment of osteoarthritis.